ANDI

by Imeka Solutions  · Based in Canada → — AI-Powered White Matter Imaging for Advanced Neuro Diagnostics
Neurology Neurosurgery Radiology
Claim this tool
Is this the maker? Claim the company →

N/a
Regulatory Status Disclosed

Overview

ANDI (Advanced Neuro Diagnostic Imaging) is an advanced quantitative imaging software developed by Imeka Solutions, Inc.. It is designed for medical professionals, particularly neurologists and radiologists, to enhance the evaluation of medical images, especially in neuroimaging. Its core function involves processing diffusion-weighted images to map the microstructural properties of white matter in the brain. ANDI provides adjunctive information for use with the complete standard of care evaluation of a patient’s brain health.

The software supports functions such as image review, basic measurements, planning, and visualization, including 3D mapping of white matter tracts from diffusion-weighted MRI sequences. It combines diffusion MRI with artificial intelligence to analyze brain damage, and includes updates like brain volumetry. ANDI generates a DICOM-encapsulated PDF report highlighting bundles with the greatest deviation from a normative range and provides a detailed analysis of all bundles’ microstructural and macrostructural values.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated radiological image processing
  • Processing of diffusion-weighted MRI sequences
  • 3D mapping of white matter tracts
  • Microstructural analysis of white matter
  • Volumetric analysis of gray matter brain structure
  • Automated segmentation of 33 fiber tracts
  • Age- and sex-matched comparison to a normative reference (1,200+ control subjects)
  • Longitudinal time points if prior studies are available
  • DICOM-encapsulated PDF report generation
  • Image review, basic measurements, planning, and visualization (MPR reconstructions)

Use Cases

  • Assessing brain damage in patients
  • Evaluating neurodegenerative diseases (e.g., Alzheimer's, Multiple Sclerosis, Parkinson's)
  • Assisting neurologists and radiologists in providing high-quality patient care
  • Quantifying neuroinflammation, demyelination, and axonal loss
  • Supporting clinical trial recruitment and tracking therapeutic effects
  • Providing adjunctive information for standard of care evaluation of brain health

What Physicians Need to Know

Brain MRI/CT Analysis
Analyzes diffusion MRI scans to create detailed maps of brain white matter. Extracts and performs microstructure analysis on 33 white matter bundles, processing diffusion-weighted images using modeling, tractography, and fiber bundling algorithms. Generates DICOM-encapsulated PDF reports detailing microstructural and macrostructural values, highlighting deviations from normative ranges. Provides multiple views of each white matter bundle and graphs showing differences from healthy white matter. Offers rapid analysis using a single shell, 5-8 minutes acquisition sequence, compatible with 1.5T or 3T MRI machines.
Neurodegenerative Disease Screening
Aids radiologists and neurologists in assessing brain damage and quantifying effects of conditions like Alzheimer's disease and multiple sclerosis by evaluating microstructural properties of white matter. Measures neuropathological markers such as neuroinflammation, axonal degeneration, and demyelination, and can gauge therapeutic effects like remyelination and tissue repair. Compares findings to normative references from a growing pool of control subjects.
Physician Tip

Leverage ANDI's detailed white matter analysis for early and precise assessment of neurodegenerative conditions and brain damage. Utilize the quantitative reports to track disease progression and evaluate therapeutic responses, especially concerning neuroinflammation, axonal degeneration, and demyelination. Integrate ANDI's insights with other clinical data for a comprehensive understanding of a patient's brain health, particularly when subtle white matter changes are suspected. The automated comparison to normative data can assist in identifying significant deviations that might be challenging to detect visually.

ANDI generates DICOM-encapsulated PDF reports, suggesting compatibility with PACS (Picture Archiving and Communication Systems) for seamless integration into existing radiology workflows. The software processes diffusion-weighted MRI images, implying direct integration with MRI scanners or image archives. The mention of CPT 3 codes for quantitative brain MRI assessment suggests potential for streamlined billing and integration with hospital financial systems.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing N/a — N/A
DeploymentCloud-based (secure cloud environment)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

ANDI received FDA 510(k) premarket authorization on July 25th, 2023 (K230913). It is a Class II medical device under regulation number 21 CFR 892.2050 (Medical Image Management And Processing System). The device is intended for display of medical images and other healthcare data, and for processing diffusion-weighted MRI sequences into 3D maps representing white matter tracts.
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ANDI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Medical Device Network
Imeka's ANDI imaging software receives FDA clearance
Imeka has received FDA 510(k) clearance for its Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software, which processes diffusion-weighted images for mapping microstructural properties of white matter in the brain.
2023-08
Florida Trend
Startup Andi Launches ChatGPT Alternative u2013 the First Generative AI Search Assistant that Provides Factually Accurate, Summarized Results
Andi, a generative AI search assistant, launched to the public after attracting 50,000 users in stealth mode, aiming to provide accurate, summarized results by using semantic search, large language models, and live data.
2023-01
PR Newswire
Atrium Announces Direct Access for Andi, the Industry-Leading AI Salesforce Development Consultant
Atrium, an AI-native Salesforce consultancy, has launched direct access to Andi, its AI agent, via a subscription service, designed to accelerate Salesforce development and configuration by up to 98% faster than manual methods.
2025-12
Q2 Investor Relations
Q2 Announces the Andiu00ae Copilot Platform Enhanced with GenAI
Q2 Holdings, Inc. announced the launch of the Andiu00ae copilot platform, an AI solution suite for bankers enhanced with Generative AI, combining Andi's proprietary knowledge model and Skills Builder framework.
2023-10
European Journal of Cardiovascular Medicine
Clinical study of Benign breast disease using ANDI (Aberrations in Normal Development and Involution) Classification and Management
A clinical study published in the European Journal of Cardiovascular Medicine assessed the utility of the ANDI (Aberrations of Normal Development and Involution) classification system in diagnosing and managing benign breast diseases.
2025-07
UNIDO
ANDIu2013Peru Meeting Strengthens the Regulatory Framework for Eco-Industrial Parks
The National Business Association of Colombia (ANDI) hosted a delegation from Peru to share experiences on developing and applying a regulatory framework for Eco-Industrial Parks (EIPs).
2025-05
Aged Care Quality and Safety Commission
ANDI | Glossary
ANDI is a digital system used by the Australian Aged Care Quality and Safety Commission (ACQSC) to manage regulatory tasks such as processing applications, receiving notifications, and storing provider information.
2026-02
Texas State University, College of Education
College of Education Boosts Research Profile with New Journal
Texas State University's College of Education is now home to Advances in Neurodevelopmental Disorders (ANDI), an international peer-reviewed journal publishing research across neuroscience, medicine, psychology, and special education.
2024-01

Videos

Product demos, reviews, and walkthroughs for ANDI.

View all on YouTube

Frequently Asked Questions

ANDI is designed for seamless integration with most common EHR systems through secure APIs, aiming to streamline tasks like documentation, data analysis, and clinical decision support. Its implementation typically involves a tailored setup to align with your practice's specific operational needs and existing digital infrastructure.
ANDI is built with robust security protocols and adheres strictly to HIPAA regulations, including end-to-end data encryption, stringent access controls, and regular security audits. Patient data is de-identified or anonymized where appropriate to safeguard sensitive health information.
ANDI differentiates itself through its specialized focus on areas like ambient clinical documentation or intelligent search capabilities and its user-centric interface. While other solutions may offer broader functionalities, ANDI aims for deep integration and precision in its core applications, often leading to higher efficiency in specific tasks.
ANDI's pricing typically operates on a subscription model, often tiered based on the number of users, specific features accessed, or the volume of data processed. Custom enterprise solutions are also available to accommodate larger healthcare systems or practices with unique requirements.
Like all AI systems, ANDI's effectiveness is influenced by the quality and diversity of its training data, which can potentially introduce biases if not meticulously managed. It is crucial to remember that ANDI serves as a decision support tool, not a replacement for clinical judgment, and its outputs should always be critically reviewed by a qualified physician.
Healthcare providers typically retain full ownership of their patient data when using ANDI. ANDI processes this data under strict contractual agreements, primarily to provide its services and to improve its algorithms in a de-identified or anonymized manner, always in compliance with data privacy regulations.
ANDI offers comprehensive onboarding training, including guided tutorials, webinars, and access to a dedicated support team to ensure smooth adoption and effective utilization. Continuous technical support, regular software updates, and educational resources are also provided as part of the service.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.